Robert B Howe

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. ncbi request reprint The WHO classification of MDS does make a difference
    Robert B Howe
    Division of Hematology, Oncology and Transplantation, University of Minnesota, Mayo Mail Code 480, 420 Delaware St SE, Minneapolis, MN 55455, USA
    Blood 103:3265-70. 2004
  2. ncbi request reprint Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients
    Milena Elimelakh
    Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA
    Haematologica 92:1029-36. 2007
  3. ncbi request reprint Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations
    Ramin Tehranchi
    Department of Medicine, Division of Hematology, Karolinska University Hospital, Karolinska Institutet, Huddinge, Stockholm, Sweden
    Clin Cancer Res 11:6291-9. 2005

Collaborators

Detail Information

Publications3

  1. ncbi request reprint The WHO classification of MDS does make a difference
    Robert B Howe
    Division of Hematology, Oncology and Transplantation, University of Minnesota, Mayo Mail Code 480, 420 Delaware St SE, Minneapolis, MN 55455, USA
    Blood 103:3265-70. 2004
    ..5 months; P =.03)...
  2. ncbi request reprint Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients
    Milena Elimelakh
    Department of Medicine, University of Minnesota Medical School, Minneapolis, MN, USA
    Haematologica 92:1029-36. 2007
    ..We report a high incidence of RCA and autoimmune hemolytic anemia (AIHA) in pancreas transplant recipients on alemtuzumab-based maintenance therapy...
  3. ncbi request reprint Antiapoptotic role of growth factors in the myelodysplastic syndromes: concordance between in vitro and in vivo observations
    Ramin Tehranchi
    Department of Medicine, Division of Hematology, Karolinska University Hospital, Karolinska Institutet, Huddinge, Stockholm, Sweden
    Clin Cancer Res 11:6291-9. 2005
    ....